MoneyWorks4Me

Pfizer informs about change in management

18 Aug 2023 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has informed that Manish Mishra - Category Lead, Vaccines will be transitioning to a different role within Pfizer Group effective September 1, 2023, and shall accordingly cease to be a Senior Management Personnel effective the said date; Sudeshna Mitra - Healthcare Solutions Partner Lead will be moving to a different role within the Company effective September 1, 2023, and shall accordingly cease to be a Senior Management Personnel from the said date.

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

5020.05 120.60 (2.46%)
12-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.00
Dr. Reddys Labs. 1198.95
Cipla 1461.55
Lupin 2264.70
Zydus Lifesciences 1204.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: